Frequently Asked Questions
Is Panacur C fenbendazole pharmaceutical grade?
Based on available information, Panacur C does not explicitly claim pharmaceutical-grade status for its fenbendazole. Consumers should look for independent lab testing certificates (CoA) to verify product quality.
What purity level does Panacur C fenbendazole have?
Panacur C does not prominently disclose specific purity percentages in publicly available materials reviewed for this article. We recommend contacting the manufacturer directly or requesting their Certificate of Analysis (CoA) before purchasing.
Are Panacur C lab test results independently verified?
Our review found that Panacur C references lab testing in its marketing materials. However, consumers should verify whether the Certificate of Analysis (CoA) was issued by an accredited, independent third-party laboratory rather than in-house testing.
How does Panacur C compare to other fenbendazole brands?
Panacur C is one of many fenbendazole supplement brands available. Key comparison factors include purity levels, third-party lab testing transparency, dosage options (222 mg), capsule count, and overall brand reputation. See our full brand comparison guide for a detailed side-by-side analysis. Panacur C received an overall rating of A in our evaluation.
What are the potential side effects of Panacur C fenbendazole capsules?
Common reported side effects of fenbendazole supplements generally include mild gastrointestinal symptoms such as nausea or stomach discomfort. Liver enzyme elevation has been noted in some protocols. We recommend consulting a healthcare provider before starting Panacur C or any fenbendazole product.
Panacur C operates in the growing fenbendazole supplement market. This independent investigation examines the company's quality claims, testing documentation, corporate legitimacy, and overall transparency to help consumers make informed decisions.
Company Background Investigation
Panacur C maintains a web presence and sells fenbendazole supplements. Our investigation examined the company's public-facing information, corporate registration, and operational history.
The company's identified location is Merck Animal Health (Intervet Inc.), USA.
Investigation Findings: Concerns
• Granules not capsules - dosing difficulty for off-label human use
• Contains excipients (77.8%)
• Intended for dogs only
Consumers should weigh these concerns carefully against any positive attributes when making purchasing decisions. In the fenbendazole market, transparency is not merely desirable — it is essential, given that consumers are ingesting products not evaluated by the FDA for human use.
Positive Findings
✅ Positive Finding
FDA-approved for dogs
✅ Positive Finding
Manufactured by Merck (major pharma)
✅ Positive Finding
Well-established safety profile in animals
✅ Positive Finding
Available at Walmart, pet stores
These positive attributes provide some basis for consumer confidence, though they should be evaluated alongside the concerns identified above.
Quality & Testing Assessment
Panacur C claims a purity level of 22.2% fenbendazole (222 mg/g) granules. Our assessment of the available testing documentation:
⚠️ Important Notice
We were unable to verify independent testing documentation for Panacur C. The testing claim is: FDA-approved veterinary product
The gold standard for fenbendazole quality verification is HPLC analysis by an independent, accredited laboratory. This testing should verify active ingredient identity and purity, heavy metals levels, microbiological safety, and residual solvents. According to published research, up to 25% of dietary supplements tested independently show significant deviations from label claims.
Safety Considerations
Fenbendazole is approved only as a veterinary anthelmintic. It has not been evaluated or approved by the FDA for any human medical condition. Documented risks include:
- Hepatotoxicity: Published case reports document elevated liver enzymes. Regular monitoring recommended.
- GI effects: Nausea, diarrhea, abdominal discomfort commonly reported.
- Drug interactions: Potential interactions with CYP450-metabolized drugs, particularly chemotherapy agents.
- Research status: Preclinical studies show promise but no human clinical trials completed.
⚠️ Important Notice
Always consult a qualified healthcare professional before starting any fenbendazole protocol. This article is for informational purposes only.
Market Context
The fenbendazole supplement market has grown dramatically since the Joe Tippens protocol gained attention. When evaluating Panacur C against competitors, key differentiators include: independent lab testing verification, manufacturing transparency, corporate identity disclosure, customer support quality, and return policy clarity.
See our complete brand comparison guide for side-by-side analysis of all fenbendazole brands we have investigated.
Final Verdict
Panacur C receives a N/A rating — Veterinary Product.
Consumers should proceed with caution and ideally request batch-specific testing documentation before purchasing from Panacur C.
📚 References & Sources
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Fenbendazole is not FDA-approved for human use. Always consult a qualified healthcare professional before starting any supplement regimen. The Fenbendazole is an independent resource.
